Recordati SpA 

$14.89
171
+$0.37+2.55% Thursday 18:31

Statistics

Day High
14.52
Day Low
14.52
52W High
17.16
52W Low
9.29
Volume
5,500
Avg. Volume
-
Mkt Cap
0
P/E Ratio
23.01
Dividend Yield
2.61%
Dividend
0.39

Upcoming

Dividends

2.61%Dividend Yield
Jun 26
$0.21
Dec 25
$0.18
Jun 25
$0.19
Dec 24
$0.16
Jun 24
$0.17
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
35.9%
1Y Growth
4.28%

Earnings

28JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.58
0.65
0.73
0.8
Expected EPS
N/A
Actual EPS
N/A

Financials

17.82%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
4.94BRevenue
880.32MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RICFY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap292.07B
Novartis is a global healthcare company that competes with Recordati in the pharmaceuticals sector, particularly in the development and marketing of prescription medications.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is a large pharmaceutical company that competes directly with Recordati in the development and distribution of drugs across various therapeutic areas.
Merck
MRK
Mkt Cap294.03B
Merck & Co. is a leading pharmaceutical company that competes with Recordati in the research, development, and marketing of drugs, especially in the areas of cardiovascular diseases.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie competes with Recordati in the pharmaceutical industry, particularly in the development of therapies for diseases in areas like immunology and oncology, which may overlap with Recordati's product offerings.
GSK
GSK
Mkt Cap106.31B
GlaxoSmithKline is a global healthcare company that competes with Recordati in the pharmaceutical and healthcare sector, including the development of medications for various diseases.
Astrazeneca
AZN
Mkt Cap277.22B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company that competes with Recordati in the development and marketing of prescription medicines, particularly in the cardiovascular, renal, and metabolism therapeutic areas.
Sanofi
SNY
Mkt Cap105.92B
Sanofi is a global healthcare leader that competes with Recordati in the pharmaceutical sector, offering a wide range of prescription medicines, vaccines, and over-the-counter healthcare products.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Recordati in the discovery, development, and delivery of medicines in areas such as cardiovascular, oncology, and immunoscience.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson is a diversified healthcare giant that competes with Recordati not only in the pharmaceutical sector but also in consumer health products and medical devices.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Recordati in the generic drug market and in the development of specialty pharmaceuticals.

About

Allegro Culture Limited, an investment holding company, provides advertising and promotional services across multiple media channels, including print media, event organizing services, and online media in Hong Kong and Mainland China. The company operates through two segments: Provision of Advertising Services; and E-commerce. The Provision of Advertising Services segment provides advertisement services on various publications and magazines, and other advertising media products. The E-commerce segment sells imported household and personal care products on e-commerce platform. It also offers IP coding optimization and refinement; publishing and investment trading; and website development and information technology services. The company was formerly known as Kingkey Intelligence Culture Holdings Limited and changed its name to Allegro Culture Limited in May 2024. Allegro Culture Limited was founded in 1992 and is headquartered in North Point, Hong Kong.
Show more...
CEO
Mr. Peng Gan
Employees
51
Country
Germany
ISIN
US75625L1008

Listings

0 Comments

Share your thoughts

FAQ

What is Recordati SpA stock price today?
The current price of RICFY is $14.89 USD — it has increased by +2.55% in the past 24 hours. Watch Recordati SpA stock price performance more closely on the chart.
What is Recordati SpA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Recordati SpA stocks are traded under the ticker RICFY.
Is Recordati SpA stock price growing?
RICFY stock has fallen by -0.43% compared to the previous week, the month change is a +40.34% rise, over the last year Recordati SpA has showed a -4.52% decrease.
When is the next Recordati SpA earnings date?
Recordati SpA is going to release the next earnings report on July 28, 2026.
What were Recordati SpA earnings last quarter?
RICFY earnings for the last quarter are 0.85 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Recordati SpA revenue for the last year?
Recordati SpA revenue for the last year amounts to 4.94B USD.
What is Recordati SpA net income for the last year?
RICFY net income for the last year is 880.32M USD.
Does Recordati SpA pay dividends?
Yes, RICFY dividends are paid semi-annual. The last dividend per share was 0.21 USD. As of today, Dividend Yield (FWD)% is 2.61%.
How many employees does Recordati SpA have?
As of June 21, 2026, the company has 51 employees.
In which sector is Recordati SpA located?
Recordati SpA operates in the Communication sector.
When did Recordati SpA complete a stock split?
The last stock split for Recordati SpA was on April 18, 2005 with a ratio of 4:1.
Where is Recordati SpA headquartered?
Recordati SpA is headquartered in North Point, Germany.